Foresite Capital Management VI LLC Diversified Active

Name: Foresite Capital Management VI LLC Q3 2025 13F Filing | 13F Explorer
Creator: Foresite Capital Management VI LLC
Published: 2025-11-14

Location: West Hollywood, CA

CIK: 0002013341 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $259M (100.0% shares, 0.0% debt)

Holdings (12)

CGON CG Oncology, Inc. 34.6%

Value $89.48M Shares 2,221,474 Est. Cost $34.21 Unrealized -15.0%

RAPT RAPT Therapeutics, Inc. 15.6%

Value $40.3M Shares 1,562,500 Est. Cost $7.63 Unrealized +71.5%

CNTA Centessa Pharmaceuticals plc 12.3%

Value $31.86M Shares 1,314,019 Est. Cost $17.10 Unrealized —

VSTM Verastem, Inc. 8.9%

Value $23.09M Shares 2,615,120 Est. Cost $6.87 Unrealized +8.4%

ALMS ALUMIS INC. 6.5%

Value $16.95M Shares 4,247,670 Est. Cost $9.97 Unrealized -58.7%

DNLI Denali Therapeutics Inc. 5.6%

Value $14.52M Shares 1,000,000 Est. Cost $14.37 Unrealized 0.0%

CRVS Corvus Pharmaceuticals, Inc. 4.9%

Value $12.76M Shares 1,731,233 Est. Cost $7.13 Unrealized -28.3%

— Akero Therapeutics, Inc. 4.5%

Value $11.63M Shares 244,900 Est. Cost $27.82 Unrealized —

KYMR Kymera Therapeutics, Inc. 3.2%

Value $8.282M Shares 146,332 Est. Cost $45.17 Unrealized -0.1%

HNGE Hinge Health, Inc. 2.6%

Value $6.626M Shares 135,000 Est. Cost $40.42 Unrealized +29.4%

RNAM Avidity Biosciences, Inc. 0.7%

Value $1.743M Shares 40,000 Est. Cost $29.81 Unrealized +35.6%

CASIF CASI Pharmaceuticals, Inc. 0.6%

Value $1.627M Shares 979,956 Est. Cost $4.16 Unrealized -57.1%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG Oncology, Inc.	2,221,474	$89.48M	34.6%	$34.21	-15.0%	COM	156944100
RAPT	RAPT Therapeutics, Inc.	1,562,500	$40.3M	15.6%	$7.63	+71.5%	COM	75382E208
CNTA	Centessa Pharmaceuticals plc	1,314,019	$31.86M	12.3%	$17.10	—	SPONSORED ADS	152309100
VSTM	Verastem, Inc.	2,615,120	$23.09M	8.9%	$6.87	+8.4%	COM	92337C203
ALMS	ALUMIS INC.	4,247,670	$16.95M	6.5%	$9.97	-58.7%	COM	022307102
DNLI	Denali Therapeutics Inc.	1,000,000	$14.52M	5.6%	$14.37	0.0%	COM	24823R105
CRVS	Corvus Pharmaceuticals, Inc.	1,731,233	$12.76M	4.9%	$7.13	-28.3%	COM	221015100
—	Akero Therapeutics, Inc.	244,900	$11.63M	4.5%	$27.82	—	COM	00973Y108
KYMR	Kymera Therapeutics, Inc.	146,332	$8.282M	3.2%	$45.17	-0.1%	COM	501575104
HNGE	Hinge Health, Inc.	135,000	$6.626M	2.6%	$40.42	+29.4%	CL A	433313103
RNAM	Avidity Biosciences, Inc.	40,000	$1.743M	0.7%	$29.81	+35.6%	COM	05370A108
CASIF	CASI Pharmaceuticals, Inc.	979,956	$1.627M	0.6%	$4.16	-57.1%	ORD SHS	G1933S101